Literature DB >> 16363238

D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.

Benilde Cosmi1, Cristina Legnani, Michela Cini, Giuliana Guazzaloca, Gualtiero Palareti.   

Abstract

We assessed the predictive value of D-dimer levels in combination with residual venous obstruction (RVO) for recurrent venous thromboembolism (VTE) in a prospective cohort of outpatients after oral anticoagulant therapy (OAT) suspension for a first episode of idiopathic proximal deep vein thrombosis of the lower limbs during a 2-year follow-up. Patients (n=400) were enrolled on the day of OAT suspension when RVO was determined by compression ultrasonography (present in 48.6% of patients). D-dimer (cut-off value: 500 ng/mL) was measured 30+/-10 days afterwards (abnormal in 56.4% of patients). The overall recurrence rate was 16.7% (67/400; 95% confidence intervals - CI -: 13-21 %). The multivariate hazard ratio (HR) for recurrence was 3.32 (95% CI: 1.78-6.75; p<0.0001) for abnormal D-dimer compared to normal D-dimer and 1.2 (95% CI:0.72-2.07; p>0.05) for RVO compared to absent RVO. The recurrence rate was 5.7% (95% CI:2-13%) and 10.4% (95% CI:6-18%), respectively, for normal D-dimer either without or with RVO, 22.9% (95% CI: 14-33%) and 25.9% (95% CI: 18-35%), respectively, for abnormal D-dimer, either without or with RVO. When compared with normal D-dimer without RVO, the multivariate HR for recurrence was similar for abnormal D-dimer either with RVO (4.76 - 95% CI:1.78-12.8) or without RVO (4.3-95%:1.56-11.88). Abnormal D-dimer at one month after OAT withdrawal is an independent risk factor for recurrent VTE, while RVO at the time of OAT withdrawal, either with normal or abnormal D-dimer after one month, does not influence the risk of recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16363238     DOI: 10.1160/TH05-02-0095

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  20 in total

1.  D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face marker.

Authors:  Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  The postthrombotic syndrome.

Authors:  Raffaele Pesavento; Sabina Villalta; Paolo Prandoni
Journal:  Intern Emerg Med       Date:  2009-12-10       Impact factor: 3.397

4.  Thrombosis: Duration of anticoagulation after VTE: guided by ultrasound?

Authors:  Henri Bounameaux; Marc Righini
Journal:  Nat Rev Cardiol       Date:  2009-08       Impact factor: 32.419

Review 5.  Predicting the risk of venous thromboembolism recurrence.

Authors:  John A Heit
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

Review 6.  Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.

Authors:  Clive Kearon
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

Review 7.  Which patients with unprovoked VTE should receive extended anticoagulation? the minority.

Authors:  Marco P Donadini; Walter Ageno
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

8.  The diagnostic yield of D-Dimer in relation to time from symptom onset in patients evaluated for venous thromboembolism in the emergency medicine department.

Authors:  Yelena Goldin; Oren Pasvolsky; Ori Rogowski; Itzhak Shapira; Arie Steinvil; Pinchas Halpern; Jack Serov; Varda Deutsch; Galit Aviram; Shlomo Berliner
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

9.  Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study.

Authors:  Bruna M Mazetto; Fernanda L A Orsi; Sandra A F Silveira; Luis F Bittar; Mariane M C Flores-Nascimento; Kiara C S Zapponi; Marina P Colella; Erich V de Paula; Joyce M Annichino-Bizzacchi
Journal:  Clin Appl Thromb Hemost       Date:  2017-04-10       Impact factor: 2.389

10.  Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Aaron R Folsom; Alvaro Alonso; Kristen M George; Nicholas S Roetker; Weihong Tang; Mary Cushman
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.